Niflumic acid and cutaneous reactions in children

被引：16
|
作者：
Menniti-Ippolito, F
Sagliocca, L
Da Cas, R
Saggiomo, G
Di Nardo, R
Traversa, G
机构：
[1] Ist Super Sanita, Dept Epidemiol & Biostat, I-00161 Rome, Italy
[2] Santobono Hosp, I-80129 Naples, Italy
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2001年 / 84卷 / 05期
关键词：
adverse drug reactions; niflumic acid; cutaneous reactions; pharmacoepidemiology;
D O I：
10.1136/adc.84.5.430
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Tn a case control study of adverse drug reactions in children, the odds ratio of developing a serious mucocutaneous event among users of niflumic acid, adjusted for concomitant use of all other drugs, was 4.9 (95% CI 1.9 to 12.8), Given the availability of safer analgesics and antipyretics, there is no indication, in our opinion, that requires the prescription of substances which bear an increased risk.
引用
收藏
页码：430 / 431
页数：2
相关论文
共 50 条
  • [41] ELECTROCHEMICAL-BEHAVIOR OF NIFLUMIC ACID - ANALYTICAL APPLICATIONS
    BOUCLY, P
    GUERNET, M
    LACROIX, J
    NIVAUD, E
    ANNALES PHARMACEUTIQUES FRANCAISES, 1979, 37 (7-8): : 263 - 268
  • [42] OUR EXPERIENCES WITH NEW ANTIRHEUMATIC AGENT NIFLUMIC ACID
    KANKOVA, D
    VOJTISEK, O
    PAVELKA, K
    HANDLOVA, D
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1974, 10 (01) : 56 - 63
  • [43] Solubility of niflumic acid and celecoxib in supercritical carbon dioxide
    Tsai, Cheng-Chou
    Lin, Ho-Mu
    Lee, Ming-Jer
    JOURNAL OF SUPERCRITICAL FLUIDS, 2014, 95 : 17 - 23
  • [44] Activation of Slo2.1 channels by niflumic acid
    Dai, Li
    Garg, Vivek
    Sanguinetti, Michael C.
    JOURNAL OF GENERAL PHYSIOLOGY, 2010, 135 (03): : 275 - 295
  • [45] RELATIONSHIPS BETWEEN ROUTE OF ADMINISTRATION AND BIOAVAILABILITY OF NIFLUMIC ACID
    DIFAZIO, L
    VUKOVICH, R
    NEISS, ES
    DARRAGH, A
    CLINICAL RESEARCH, 1976, 24 (03): : A508 - A508
  • [46] HISTOLOGICAL OSTEOMALACIA INDUCED BY PROLONGED ADMINISTRATION OF NIFLUMIC ACID
    BONVOISIN, B
    BOUVIER, M
    MEUNIER, PJ
    LEJEUNE, E
    NOUVELLE PRESSE MEDICALE, 1982, 11 (21): : 1636 - 1636
  • [47] Reduced gastric toxicity of niflumic acid/cyclodextrin systems
    Iervolino, M
    Quaglia, F
    Miro, A
    Calignano, A
    Cappello, B
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2004, 14 (01) : 93 - 96
  • [48] Experimental Analysis of Complex Formation of Niflumic Acid with β-Cyclodextrins
    Irina V. Terekhova
    Tatyana V. Volkova
    German L. Perlovich
    Journal of inclusion phenomena and macrocyclic chemistry, 2006, 55 : 335 - 340
  • [49] INTRACELLULAR BINDING OF THE ANTIINFLAMMATORY DRUG NIFLUMIC ACID IN THE LIVER
    KELMERBRACHT, AM
    ISHIIIWAMOTO, EL
    BRACHT, A
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 89 (03) : 411 - 419
  • [50] NIFLUMIC ACID A NEW ANTI-INFLAMMATORY AGENT
    WAREMBOURG, H
    DUCLOUX, G
    LILLE MEDICAL, 1969, 14 (3S2): : 241 - +
12345